Journal of Biopharmaceutics Sciences (JBS)

Journal of Biopharmaceutics Sciences (ISSN: 2329-8200, eISSN: 2329-8197) provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics. Journal of Biopharmaceutics Sciences (JBS) is a collaborated publishing project under Zibeline International and Academic Research Publishers.

INDEXED BY :

Introduction

Biopharmaceutical Science involves study of the discovery, development and processing of modern, medical drugs by artificially growing some or all of the components utilising cell culture technologies. The processes involved are more biological-based as compared to the more chemical-based processes associated with small-molecule pharmaceutical products. The Medical Biotechnology and Biopharmaceutical sectors are among the fastest growing in the Life Sciences area both nationally and internationally.

They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. Biopharmaceuticals are medical drugs produced using biotechnology. They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. The first such substance approved for therapeutic use was recombinant human insulin (rHI, trade name Humulin), which was developed by Genentech and marketed by Eli Lily in 1982. The large majority of biopharmaceutical products are pharmaceuticals that are derived from life forms. Small molecule drugs are not typically regarded as biopharmaceutical in nature by the industry.

Aims & Scope

Journal of Biopharmaceutics Sciences (ISSN: 2329-8200, eISSN: 2329-8197) provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.

Topics covered include:
• Drug and pro-drug design, drug stability and drug development
• Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals
• Physical pharmacy, drug delivery systems, controlled release systems and drug targeting
• Biopharmaceutics
• Pharmaceutical analysis and pharmaceutical packaging
• Quality control, GMP and regulatory aspects
• Medical devices

Peer Review Policy
All peer review is single blind and submission is online via Editorial Manager.

Article publishing charge
There is no APC from 2017 to 2020. Authors will pay $300 only from 2021 onwards.

Submission charges
There are no submission charges for this journal.